Thyroid fine needle aspiration cytology (FNAC) is one of the most frequently performed medical procedures worldwide. We report one such difficult case that required integration of clinical, morphological and immunohistochemical findings to reach a correct diagnosis.
| INTRODUCTION
Thyroid fine needle aspiration cytology (FNAC) is one of the most frequently performed medical procedures worldwide. 1 It is used as a diagnostic test to separate benign thyroid nodules (colloidal and hyperplastic nodules) from thyroid malignancies, either primary (papillary thyroid carcinoma [PTC] , medullary thyroid carcinoma, poorly differentiated thyroid carcinoma [PDTC] , anaplastic thyroid carcinoma
[ATC]) or, less often, metastatic. 2 The negative and positive predictive values of this procedure in The Bethesda System for Reporting Thyroid Cytopathology are, respectively, 97% and 98% for the benign and malignant categories. 3 Being so frequent a procedure, it is not rare in general cytopathology practice to encounter unusual lesions that pose diagnostic problems. The modern cytopathologist should also be aware of the clinical setting in which a lesion is aspirated and should interpret cytomorphology and ancillary tests results as a whole, to maintain high thyroid FNAC diagnostic accuracy.
We report one such difficult case that required integration of clinical, morphological and immunohistochemical findings to reach a correct diagnosis.
| CASE HISTORY
A 54-year-old man with unremarkable past medical history presented with a rapidly growing right laterocervical nodule that, as he said, had become palpable within a month. However, he also complained of pharyngeal discomfort with right shoulder pain for several months. On examination, the patient was in overall good physical condition. Cervical palpation confirmed a diffusely enlarged right thyroid lobe, as well as a right cervical mass measuring approximatively 5 cm. No sign of thyroid dysfunction was noted.
A cervical ultrasound (US) confirmed the clinical appreciation and revealed multiple and bilateral enlarged lymph nodes, all of them with highly suspicious features. This presentation suggested a primary malignant thyroid neoplasm with local metastatic spread. FNAC under US guidance was then performed on the right thyroid lobe and the largest pathological lymph node. Following a cytopathological diagnosis of a high-grade B-cell lymphoma, a lymph node biopsy was performed for precise subtyping and final diagnosis. Meanwhile, 18-fludeoxyglucose positron emission tomography/computed tomography revealed multiple pathological uptake in the liver and spleen, as well as in the previously described cervical lesions.
| MATERIALS AND METHODS, RESULTS
Cervical echography showed a 3. or ATC can be readily made. 7, 8 In the case of our patient, a combination of clinical and morphological aspects, were not fully compatible with our first cytomorphological impression and prevented a diagnosis of PDTC or ATC.
Clinically, ATC usually presents as a thyroid mass with wide extrathyroidal extension. 8 Laterocervical lymph node metastasis is not so frequent. Immediate symptoms related to brisk extrathyroidal infiltration often lead to a high clinical suspicion of ATC. In our case, the patient symptoms appeared progressively, and the US examination of the thyroid and neck were not pathognomonic of an ATC.
However, the absence of CK, thyroglobulin and TTF-1 expression coupled with retained Pax-8 expression were still favouring a diagnosis of ATC. 9 Retrospectively, additional CKs could have been tested to decrease the possibility to be dealing with an ATC. CK7 alone or as part of a cytokeratin cocktail such as AE1/AE3 or MNF-116 would have been an appropriate addition, as it is reported that CK7 and CK18 are expressed in 84% and 80% of ATC, respectively. 10 Moreover, use of Pax-8 is encouraged in undifferentiated thyroid tumours with limited or no expression of TTF-1 and cytokeratins. 9 Clinically, a well-delineated thyroid nodule associated with regional metastatic lymph node would be more consistent with a metastatic PTC or PDTC. The first hypothesis was excluded by the absence of typical PTC nuclei and by the absence of cytokeratin and TTF-1 expression.
As for PDTC, absence of papillary or follicular architecture, severe crowding, single cells, and high nuclear/cytoplasmic ratio were the most predictive diagnostic features. 11 Despite partly compatible cytomorphology, the absence of cytokeratin, thyroglobulin and TTF-1 expression is atypical for a PDTC, as it is known to show diffuse expression of TTF-1 and at least to retain some expression of thyroglobulin. Concerning markers of lymphoid lineage, as already mentioned, there are some known overlapping stainings among lymphoma and carcinoma that can be troublesome in some situations. 4, 5 CD20 is expressed in 14.8% and 8.2% of the encapsulated and infiltrative variants of PTC, respectively, as well as in metastatic PTC. 14 CD45 can even be exceptionally expressed by undifferentiated carcinoma. 5 As for Pax-5, apart from positivity reported in few Merkel cell carcinoma 16 (along with coexpression of TTF-1), the monoclonal Pax-5 antibody we tested seems to be the most discriminant marker in the differential diagnosis between an ATC and a high-grade B-cell lymphoma.
In conclusion, we would like to draw attention to certain aspects of this case that we found interesting. Identifying the origin and nature of a poorly differentiated tumour cannot rely only on immunohistochemical panels and has to be considered along with detailed clinical information and an appropriate morphological analysis. Polyclonal antibodies are easy to produce and thus cheaper, but they are less specific than their monoclonal counterparts and thus have to be interpreted carefully, above all in situations as the one presented here, where a single anti- 
